Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To assess the efficacy of omalizumab (Xolair) in adolescent and adult patients with cystic fibrosis (CF) complicated by acute or chronic allergic bronchopulmonary aspergillosis (ABPA) •as measured by the proportion of patients requiring rescue with corticosteroids following 6 months of study treatment •as measured by time to deviation from the protocol prescribed steroid tapering regime
Critère d'inclusion
- Patients with cystic fibrosis complicated by allergic bronchopulmonary aspergillosis